Teriflunomide
| Use attributes for filter ! | |
| Molar mass | 270. 207 g/mol |
|---|---|
| Formula | C12H9F3N2O2 |
| Other names | A77 1726 |
| Trade name | Aubagio |
| Pregnancy category | US |
| Elimination half-life | 2 weeks |
| Music groups | Dimethyl fumarate |
| Fingolimod | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 3016378 |
About Teriflunomide
Teriflunomide, sold under the brand name Aubagio, is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis. The study was completed in July 2010. 2-year results were positive.